Next Article in Journal
The Stability of TiO2 Phases Studied Using r2SCAN in the Hubbard-Corrected Density Functional Theory
Previous Article in Journal
Effect of Different Enzyme Treatments on Juice Yield, Physicochemical Properties, and Bioactive Compound of Several Hybrid Grape Varieties
Previous Article in Special Issue
Chemical Profile and Biological Properties of Methanolic and Ethanolic Extracts from the Aerial Parts of Inula britannica L. Growing in Central Asia
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Marchantia polymorpha as a Source of Biologically Active Compounds

by
Filip Nowaczyński
1,*,
Rosario Nicoletti
2,*,
Beata Zimowska
3 and
Agnieszka Ludwiczuk
1
1
Department of Pharmacognosy with the Medicinal Plant Garden, Medical University of Lublin, 20-093 Lublin, Poland
2
Council for Agricultural Research and Economics, Research Center for Olive, Fruit and Citrus Crops, 81100 Caserta, Italy
3
Department of Plant Protection, University of Life Sciences, 20-069 Lublin, Poland
*
Authors to whom correspondence should be addressed.
Molecules 2025, 30(3), 558; https://doi.org/10.3390/molecules30030558
Submission received: 24 December 2024 / Revised: 20 January 2025 / Accepted: 24 January 2025 / Published: 26 January 2025
(This article belongs to the Special Issue Biological Activity of Plant Extracts)

Abstract

:
Marchantia polymorpha L., also known as common liverwort or umbrella liverwort, is a spore-forming plant belonging to the Marchantiaceae family. This thallose liverwort has gained importance as a model plant, mainly because of its global distribution and easy and rapid in vitro culturing. A review of the literature shows that the major compounds in this species are undoubtedly sesquiterpenoids and bisbibenzyls. Among the sesquiterpenoids, it is worth mentioning cuparenes, chamigranes, and thujopsanes. Compounds belonging to these classes were found in specimens from Japan, China, Poland, Germany, and India and could be the chemical markers of this liverwort species. The key secondary metabolite of M. polymorpha is a macrocyclic bisbibenzyl, marchantin A. Marchantin-type aromatic compounds, together with other bisbibenzyls, such as riccardin D, isoriccardin C, or perrottetin E, demonstrated antifungal and antibacterial properties in various studies. In this review, we summarize the current knowledge on the diversity of compounds produced by M. polymorpha, emphasizing chemical variability depending on the origin of the plant material. Moreover, the biological activity of extracts obtained from this liverwort species, as well as single secondary metabolites, are described.

1. Introduction

Bryophytes are terrestrial, spore-bearing plants that comprise three phyla: liverworts (Marchantiophyta), mosses (Bryophyta), and hornworts (Anthocerophyta). These small nonvascular plants, phylogenetically placed between algae and ferns, are considered the first inhabitants of terrestrial habitats [1]. As the first land plants, they had to cope with adverse environmental conditions; hence, their ability to synthesize many different specialized secondary metabolites is extremely high. Indeed, such ‘chemical weapons’ are necessary for these small plants, since they the lack mechanical protection of higher vascular plants [2]. Among the bryophytes, the chemical constituents of the Marchantiophyta and their biological activity have been studied in great detail. Over the last 40 years, more than 3000 compounds have been found in this group of plants. Many of these products are characterized by unprecedented structures, and some, including the pinguisane-type sesquiterpenoids and the sacculatane-type diterpenoids, have not been found in any other plants, fungi, or marine organisms. This unique chemical composition increases the number of potential applications in medicine and beyond. In fact, the available literature data indicate that liverwort secondary metabolites show antibacterial, antifungal, cytotoxic, insect repellant, enzyme inhibitory, and proapoptotic activities [3,4,5].
Marchantia polymorpha L., also known as common liverwort or umbrella liverwort and belonging to the Marchantiaceae family (Figure 1), is the most widely distributed liverwort in the world. It is a cosmopolitan species that occurs from tropical to arctic regions [6,7].
This liverwort species has become one of the most important models for plant biology research and evolutionary genomics due to its relatively simple genome, global distribution, easy in vitro culturing, and unique phylogenetic position as a member of the early land plants [8,9]. As an evolutionary model, M. polymorpha contributes to our understanding of the evolution of plant defensive responses and the associated hormonal signaling pathways [9]. At this point, the following questions arise about the biologically active compounds present in this model plant: What do we know about them? Does Marchantia have its own characteristic metabolites? And are they used in medicine, horticulture, or for other purposes?
The aim of this paper is to review the available scientific literature concerning both the chemical composition and the biological properties of the most well-known liverwort species, M. polymorpha. Special attention was paid to the variability of the chemical composition depending on the origin of the plant material.

2. Chemical Diversity of M. polymorpha

Liverworts (Marchantiophyta) are plants that produce a wide array of biologically active secondary metabolites. These compounds are accumulated in the oil bodies, which are prominent and highly distinctive organelles uniquely found in liverworts [10]. Oil bodies are present in 95% of all liverwort species and are intracellular organelles bounded by a single unit membrane originating from dilated endoplasmic reticulum cisternae, containing lipophilic globules [11]. In the thallose liverworts like M. polymorpha, oil bodies are confined to scattered idioblastic oil body cells, while oil bodies of leafy liverworts are generally present in all cells [12]. The number, size, and colour of oil bodies are species specific. Oil bodies are estimated to serve a protective role for the plant, with their contents postulated to protect the plant against various biotic and abiotic stressors [13].
A review of the literature on the chemical composition of the umbrella liverwort shows that it is characterized by great diversity. The following groups of chemical compounds have been identified so far in Marchantia: monoterpenoids, sesquiterpenoids, and diterpenoids; sterols and triterpenoids; and bibenzyls, bisbibenzyls, phenanthrene derivatives, flavonoids, lipids, and other compounds (Table 1).
Such a great chemical diversity of M. polymorpha, shown in Table 1, suggests the heterogeneity of this liverwort species. Marchantia is characterized by high morphological variability, which has led to the description of many synonymous “species” and subspecific taxa [8]. Based on the analysis of morphological characters, isozyme patterns, RFLP (nrDNA), RAPD markers, and ecological preferences, three subspecies of M. polymorpha are distinguished. These are M. polymorpha subsp. polymorpha, M. polymorpha subsp. montivagans, and M. polymorpha subsp. ruderalis. The available literature data indicate that the subsp. polymorpha corresponds to the plant previously known as Marchantia aquatica, while the subsp. montivagans corresponds to the liverwort known as Marchantia alpestris. Only the subsp. ruderalis corresponds to M. polymorpha (sensu stricto). These three taxa differ in habitat, although they sometimes occur sympatrically [55,56,57]. More detailed analyses conducted by Linde and his associates [58] revealed a more complex pattern, with evidence suggesting hybridization and introgression between subspecies.
When reviewing the literature on chemical composition, unfortunately, there is almost no data on the occurrence of plant metabolites in individual subspecies. Most of the publications refer simply to M. polymorpha without indicating the subspecies. The data included in Table 1 suggest that most of the metabolites were identified and/or isolated from subsp. ruderalis. This is also supported by the ecological preferences of individual subspecies. Boisselier-Dubayle and coworkers [55] showed that M. polymorpha subsp. polymorpha occurs chiefly in flooded habitats, and subsp. montivagans grows in wet habitats in the mountains, while subsp. ruderalis colonizes preferentially man-made habitats, implying that, when collecting plant material, it is easiest to encounter M. ruderalis.
The phytochemistry of M. polymorpha also varies depending on its place of origin. The major chemical compounds contributing to the phytochemical complexity of this liverwort species are distributed among two groups: sesquiterpenoids and bisbibenzyls. A comparison of the chemical composition of the available data concerning subspecies, as well as geographical distribution in relation to the most characteristic metabolites of M. polymorpha, are presented in Table 2.

2.1. Sesquiterpenoids

Marchantia polymorpha is a rich source of terpenoids, in particular those belonging to the sesquiterpene group. Forty-eight sesquiterpenoids belonging to twenty different classes are included in Table 1. The structures of selected sesquiterpenoids characteristic of M. polymorpha are presented in Figure 2.
The first sesquiterpenoid reported from M. polymorpha was (S)-2-hydroxycuparene (=2-cuparenol). Its isolation was conducted in 1974 by Hopkins and Perold [26] from a South African specimen. Two cuparane-type alcohols, cyclopropanecuparenol and its epimer, are the major volatile components of this species. Besides the mentioned alcohols, other cuparanes are present in M. polymorpha, namely cuparene and α-, β-, γ-, and δ-cuprenene. Thujopsanes and chamigranes are other sesquiterpenoids characteristic of M. polymorpha. They are represented by thujopsene, thujopsan-7β-ol, thujopsenone, α- and β-chamigrene, as well as ent-9-oxo-α-chamigrene [12,18]. The data included in Table 2 show that these sesquiterpenoids (cuparanes, chamigranes, and thujopsanes) could be chemical markers of M. polymorpha subsp. ruderalis. Occasionally, this subspecies can produce metabolites characteristic of a single specimen. In the Polish collection of M. polymorpha, acorane-type sesquiterpenoids were identified. The presence of α-neocallitropsene, acorenone B, β-alaskene, and β-acoradiene were confirmed [59,60].
Our recent preliminary data concerning volatile components present in the Serbian M. polymorpha subspecies showed that the subspecies polymorpha and montivagans are very different with reference to sesquiterpene composition. In the case of these subspecies, the presence of cuparane-, chamigrane-, and thujopsane-type compounds was not demonstrated, while compounds belonging to aromadendranes, guaianes, and eudesmanes were identified [17]. A very similar chemical composition was also observed in the sample from Turkey [16]. Although the authors did not specify the subspecies of the specimen studied, it can be inferred that it is not M. ruderalis.

2.2. Bibenzyls and Bisbibenzyls

Bibenzyls are organic compounds with a C6-C2-C6 skeleton, which are synthesized by the phenylpropanoid pathway, like polyphenols [61]. Common liverwort is reported to produce only a few compounds; among them, it is worth mentioning lunularin and lunularic acid [23,26,62]. Both metabolites are direct precursors in the biosynthesis of marchantin C, a bisbibenzyl, which is later transformed to form marchantin A [63].
Bisbibenzyls are macrocyclic compounds consisting of two bibenzyl units. Acyclic bisbibenzyl compounds are linked once, while the cyclic ones are linked twice. The most important bisbibenzyl found in M. polymorpha is marchantin A. It is derived from lunularic acid, with two ether linkages between C1–C2′ and between C14–C11′ (Figure 3). The majority of common liverwort specimens contain marchantin A in large amounts. In fact, it was reported to be present in common liverwort from various countries (Table 1). This, however, is not true for South African M. polymorpha, which, according to some studies, does not contain marchantin A at all [33]. Its place as the major cyclic bisbibenzyl is taken by marchantin H. Moreover, marchantin E has been isolated form Indian and French specimens [5]. Marchantin A is also commonly found in many other plants from the Marchantiales [64,65] and other Marchantiophyta [66].
Riccardins are another group of cyclic bisbibenzyl compounds present in M. polymorpha. Japanese and Indian specimens of M. polymorpha contain riccardin C [13,22,40]. Riccardin H, isoriccardin D, and 13,13′-O-isopropylidenericcardin D were found in M. polymorpha from China [62]. Isoriccardin C was found in Chinese, Indian, and Vietnamese plant material [13,62,67].
Other bisbibenzyls that can be found in common liverwort are perrottetin E and polymorphatin A. Perrottetin E is an acyclic bisbibenzyl found in Indian and Chinese specimens of common liverwort [13,62]. It can be used as a precursor for the synthesis of marchantin- and riccardin-type compounds [33]. Polymorphatin A is a cyclic compound linked with one ether C1–C2′ linkage and one biphenyl C12–C12′ linkage. This bisbibenzyl was first found in Chinese M. polymorpha [62]. Representatives of riccardins and other bisbibenzyls are presented in Figure 4.
Based on the data presented in Table 2, specimens from European countries and Japan are characterized by the occurrence of only marchantin A derivatives. On the other hand, those from India, China, and Vietnam, as well as South Africa, in addition to marchantin-type compounds, also produce those belonging to the riccardin and perrottetin types.

2.3. Other Compounds

Flavonoids are ubiquitous minor components in the Marchantiophyta, including M. polymorpha [3,4,68]. The main flavonoid types present in this species are flavone O-glucuronides. Luteolin, apigenin, and their derivatives are the most abundant, as shown in Table 1.
Another interesting biochemical feature of M. polymorpha is represented by two polyunsaturated fatty acids, arachidonic acid (ARA, 20:4n-6) and eicosapentenoic acid (EPA, 20:5n-3). Shinmen et al. [54] have reported that culture of M. polymorpha contained high amounts of ARA and EPA (92 and 48 mg L−1, respectively) under photomixotrophic conditions.
Among other products of M. polymorpha, it is worth mentioning monoterpenoids and diterpenoids, sterols and triterpenoids, phenanthrenes, phthalides, and other aromatic compounds. Characteristic diterpenoids can be found in Vietnamese specimens, such as marchanol, belonging to the clerodane-type compounds, and vitexilactone from the labdane group [31].
Marchantia polymorpha does not synthesize monoterpenes, apart from limonene, which was reported at the initial stage of growth in cell culture [14].
The sterols and triterpenoids found in common liverwort are similar to those found in the higher plants. Among the sterols, the presence of sitosterol and stigmasterol was confirmed, while among triterpenoids, the occurrence of ursane- and oleanane-type compounds was reported [22,31,33]. Phenanthrene derivatives were found in the field collection of M. polymorpha from India [23], as well as from cell cultures in Germany [37]. Finally, the presence of two phthalides, 3R-(3,4-dimethoxybenzyl)-5,7-dimethoxyphthalide and marchatoside, was confirmed in a Vietnamese collection [31].
The chemical structures of selected diterpenoids and triterpenoids, flavonoids, phenanthrenes, and phthalides are presented in Figure 5.

3. Biological Activities

Common liverwort has a long history in ethnomedicine [64]. It was used as an antipyretic, antihepatic, antidotal, and a diuretic medicinal plant [69].
Extracts of M. polymorpha were repeatedly proven to possess antifungal properties [42,70,71,72,73]. Many fungi are susceptible to growth inhibition when subjected to these extracts, including Candida albicans [35,70,74], Cryptococcus neoformans, Tilletia indica, Fusarium oxysporum f.sp. lini, Sclerotium rolfsii, Rhizoctonia solani [42,71], Alternaria solani [74], Fusarium solani [73], and Trichophyton mentagrophytes [35,74]. Studies of activity against C. albicans determined that neomarchantin A, riccardin D, and 13,13′-O-isopropylidene-riccardin D are the most effective compounds, while marchantin A, B, and E and riccardin H, even if possessing some antifungal activity, were not as effective [70]. The activity also varies depending on the solvent used for extraction. Riccardin D (called by the authors plagiochin E), found in Chinese M. polymorpha, exhibits inhibitory properties against C. albicans, which were increased when combined with fluconazole. When examined in more detail, this compound was found to reverse the fungal resistance to the azole drug by inhibiting its efflux from C. albicans [75]. Transmission electron microscopy showed serious damage in the structure of the yeast cell wall after treatment with plagiochin E. Inhibition of chitin synthesis was detected, deriving from downregulation of the expression of CHS1 and upregulation of the expression of CHS2 and CHS3 [76]. Moreover, exposure to plagiochin E resulted in an elevation of the membrane potential and a decrease of the ATP level in mitochondria, which caused ROS accumulation [77]. This effect induced typical markers of apoptosis in the yeast cells, such as chromatin condensation, nuclear fragmentation, and G2/M cell cycle arrest. The latter event was related to downregulation of cyclins (CDC28, CLB2 and CLB4), as well as metacaspase activation [78].
Antibacterial activity of extracts from M. polymorpha is also an important subject of studies on common liverwort, although no information has been collected so far with reference to the mechanisms of action. Besides the crude extracts [71,74], marchantin A also exhibits such properties; in fact, its inhibitory effect has been documented on both Gram-positive and Gram-negative bacteria, such as Acinetobacter calcoaceticus, Bacillus cereus, Bacillus megaterium, Bacillus subtilis, Escherichia coli, Haemophilus influenzae, Listeria monocytogenes, Neisseria meningitidis, Pasteurella multocida, Pseudomonas aeruginosa, Proteus mirabilis, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, and Streptococcus viridans [23,42,62,68,79,80]. Antibacterial effects have been also documented in the case of isoriccardin C [62]. Lines of M. polymorpha were also subjected to genetic engineering in order to obtain a mutant with a higher potential for the synthesis of antibacterial compounds [35].
In vitro studies have shown that organic extracts of M. polymorpha exhibit cytotoxic activity [81,82], deriving from their content in bioactive products. A more detailed study conducted in 2008 showed that marchantin A induces growth inhibition on the breast cancer cell lines A256, MCF-7, and T47D, based on an antimicrotubular effect which was increased when marchantin A and an Aurora-A kinase inhibitor were used simultaneously [83]. Marchantin A also demonstrated cytotoxicity against the malignant melanoma cell line A375 while having less cytotoxic activity against keratocytes and not affecting tyrosinase activity in a model assay [84]. Lunularin also exhibited potent cytotoxic activity against MCF-7 [62].
Marchantin A exhibits DNA polymerase β-inhibitory and anti-HIV activities [85]. Moreover, along with marchantins B and E, plagiochin A, and perrottetin F, it possesses anti-influenza activity deriving from its targeting of the PA subunit of endonuclease. These products have a 3,4-dihydroxyphenethyl group in common, which is indicative of the importance of this moiety for this kind of bioactivity [86]. Marchantin A was also found to inhibit the proliferation of the erythrocytic stages of two Plasmodium falciparum strains, as well as other protozoans, such as Trypanosoma brucei rhodesiense, T. cruzi, and Leishmania donovani [87]. Its antitrypanosomal activity was also documented by another research group, along with marchantin E [88]. However, marchantin A has a low sensitivity index towards the aforementioned parasites, so the therapeutic window is rather narrow [1].
While tested for its antioxidant properties, marchantin A showed free radical scavenging ability [35] depending on its concentration. It also ties in to the anti-inflammatory properties of M. polymorpha, originating in its ethnomedicinal uses. Marchantins A, B, D, and E, isoriccardin C, and perrotetin D demonstrated an inhibitory effect on 5-lipoxygenase and cyclooxygenase, key enzymes in the arachidonic acid cascade [89]. The strength of this effect is structure dependent, as marchantin D exhibited lower inhibition toward 5-lipoxygenase. Along with lunularin, isoriccardin C has also displayed strong DPPH radical scavenging activity [62].
A chloroform extract of M. polymorpha was postulated to have hepatoprotective properties [90]. When mice were administered with paracetamol in liver-damaging quantities along with marchantin A, the amount of markers of liver damage in mice blood (aspartate transaminase and alanine transaminase) was significantly lower than in the control group administered with paracetamol only, and on par with the group in which paracetamol was administered along with silymarin. Another study showed that flavonoids of M. polymorpha can protect liver cells from injuries caused by the administration of carbon tetrachloride [91]. As both compounds induce damage to liver cells with their oxidizing potential, the hepatoprotective effect was postulated to be due to the antioxidant properties of M. polymorpha extracts.
Marchantin A, riccardin A, marchantin B, and other compounds from M. polymorpha also have an inhibitory effect on lipopolysaccharide production induced by nitric oxide [92]. As nitric oxide is postulated to play a role in the etiology of chronic neurodegenerative diseases [93], this property should be more closely investigated in the future.
Structural similarity between cyclic bisbibenzyl compounds and bisbenzylisoquinoline alkaloids, such as tubocurarine, has led to the investigation of the muscle relaxation properties of marchantin-type compounds [94]. In a study published in 1995 [95], marchantin A was used in comparison to cepharanthine, a muscle relaxant. Both compounds expressed similar properties and were bound to a common receptor, which points to the muscle-relaxing properties of marchantin A likely being owed to the binding of calcium molecules. This may also tie in with the inhibition by marchantin A of calmodulin [95], a protein with activity related to calcium levels in the cell.

4. Conclusions and Future Perspectives

Although bryophytes are among the oldest land plants, their usefulness is relatively unknown to most people. There is very little knowledge available about the medicinal properties of bryophytes. An ancient method of determining the medicinal properties of plants was based on the concept of Paracelsus, dealing with the resemblance of plant body parts to the shape and structure of organs in the human or animal body for which it is remedial. As per the abovementioned philosophy, M. polymorpha was used to cure hepatic disorders [96]. This liverwort was also used as a medicine for boils and abscesses, perhaps because the young archegoniophore resembles a boil when it first emerges from the thallus [97].
From this perspective M. polymorpha became a very interesting case study. This liverwort is present in almost all environments and has a very versatile phytochemical profile, especially including bisbibenzyl compounds. These compounds are almost unique to liverworts, as their presence has so far only been confirmed for plants of the Primula genus [1,5]; they have disclosed particular interest in biological activity studies and may be the foundation of new plant medicines or plant protection products.
However, until now, no products derived from M. polymorpha are available on the market. Also, to the best of our knowledge, no clinical, pre-clinical or toxicological studies have been carried out so far. Although the exact mode of action of some of the described bioactive compounds remains unknown, M. polymorpha and its metabolites could serve as an attractive candidate for therapeutic properties. Further work on the isolation, characterization, structural elucidation, pharmacological evaluation, determination of mode of action, and clinical trial of these active principles could open exciting perspectives in future drug development programs.
The secondary metabolites of M. polymorpha endophytes show applicative potential as well. They exhibit selective cytotoxicity toward several cancer cell lines and antiviral properties [15,98], calling for more accurate investigations on their occurrence and bioactivities. As of late, our team is trying to establish the optimal ways to cultivate these bryendophytes and to extract and evaluate their products.
As we managed to summarize in this article, the therapeutic potential of M. polymorpha is yet to be fully explored, but, even now, it holds potential for many future studies, which may result in crucial findings.

Author Contributions

Conceptualization, A.L., F.N. and B.Z.; methodology, A.L.; formal analysis, R.N.; investigation, F.N.; resources, A.L.; data curation, B.Z. and A.L.; writing—original draft preparation, F.N, B.Z. and A.L.; writing—review and editing, R.N.; visualization, A.L. and F.N.; supervision, R.N.; project administration, A.L.; funding acquisition, R.N. and A.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by project 101135305—HORIZON-CL6-2023-CircBio-01-4 (Bioprospecting and production of bioactive molecules from European bryophytes ‘BRYOMOLECULES’).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created.

Acknowledgments

The authors gratefully acknowledge the contribution of Yoshinori Asakawa (Tokushima Bunri University, Japan) for the valuable scientific discussion and photos of umbrella liverwort.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Asakawa, Y.; Ludwiczuk, A. Chemical Constituents of Bryophytes: Structures and Biological Activity. J. Nat. Prod. 2018, 81, 641–660. [Google Scholar] [CrossRef] [PubMed]
  2. Ludwiczuk, A.; Asakawa, Y. Bryophytes as a Source of Bioactive Volatile Terpenoids—A Review. Food Chem. Toxicol. 2019, 132, 110649. [Google Scholar] [CrossRef] [PubMed]
  3. Asakawa, Y. Chemical Constituents of the Bryophytes. In Progress in the Chemistry of Organic Natural Products; Herz, W., Kirby, G.W., Moore, R.E., Steglich, W., Tamm, C., Eds.; Springer: Vienna, Austria, 1995; Volume 65, pp. 1–618. ISBN 978-3-7091-6896-7. [Google Scholar]
  4. Asakawa, Y. Chemical Constituents of the Hepaticae. In Progress in the Chemistry of Organic Natural Products; Herz, W., Grisebach, H., Kirby, G.W., Heidelberger, M., Eds.; Springer: Vienna, Austria, 1982; Volume 42, pp. 1–285. ISBN 978-3-7091-8677-0. [Google Scholar]
  5. Asakawa, Y.; Ludwiczuk, A.; Nagashima, F. Chemical Constituents of Bryophytes. Bio- and Chemical Diversity, Biological Activity, and Chemosystematics. In Progress in the Chemistry of Organic Natural Products; Kinghorn, A., Falk, D., Kobayashi, J., Eds.; Springer: Vienna, Austria, 2013; Volume 95, p. 25. [Google Scholar]
  6. Bischler-Causse, H. Marchantia L. The Asiatic and Oceanic Taxa. In Bryophytorium Bibliotheca; Cramer: Vaduz, Liechtenstein, 1989; Volume 38. [Google Scholar]
  7. Bischler-Causse, H. Marchantia L. The European and African Taxa. In Bryophytorium Bibliotheca; Cramer: Stuttgart, Germany, 1993; Volume 45. [Google Scholar]
  8. Kijak, H.; Łodyga, W.; Odrzykoski, I.J. Sequence Diversity of Two Chloroplast Genes: Rps4 and tRNAGly (UCC), in the Liverwort Marchantia polymorpha, an Emerging Plant Model System. Acta Soc. Bot. Pol. 2018, 87, 3573. [Google Scholar] [CrossRef]
  9. Poveda, J. Analysis of Marchantia polymorpha–Microorganism Interactions: Basis for Understanding Plant–Microbe and Plant–Pathogen Interactions. Front. Plant Sci. 2024, 15, 1301816. [Google Scholar] [CrossRef] [PubMed]
  10. Asakawa, Y.; Toyota, M.; Tori, M.; Hashimoto, T. Chemical Structures of Macrocyclic Bis(Bibenzyls) Isolated from Liverworts (Hepaticae). Spectroscopy 2000, 14, 149–175. [Google Scholar] [CrossRef]
  11. Suire, C. A Comparative, Transmission-Electron Microscopic Study on the Formation of Oil Bodies in Liverworts. J. Hattori Bot. Lab. 2000, 89, 209–232. [Google Scholar] [CrossRef]
  12. He, X.; Sun, Y.; Zhu, R.-L. The Oil Bodies of Liverworts: Unique and Important Organelles in Land Plants. Crit. Rev. Plant Sci. 2013, 32, 293–302. [Google Scholar] [CrossRef]
  13. Romani, F.; Banić, E.; Florent, S.N.; Kanazawa, T.; Goodger, J.Q.D.; Mentink, R.A.; Dierschke, T.; Zachgo, S.; Ueda, T.; Bowman, J.L.; et al. Oil Body Formation in Marchantia polymorpha Is Controlled by MpC1HDZ and Serves as a Defense against Arthropod Herbivores. Curr. Biol. 2020, 30, 2815–2828.e8. [Google Scholar] [CrossRef]
  14. Kumar, S.; Kempinski, C.; Zhuang, X.; Norris, A.; Mafu, S.; Zi, J.; Bell, S.A.; Nybo, S.E.; Kinison, S.E.; Jiang, Z.; et al. Molecular Diversity of Terpene Synthases in the Liverwort Marchantia polymorpha. Plant Cell 2016, 28, 2632–2650. [Google Scholar] [CrossRef] [PubMed]
  15. Stelmasiewicz, M.; Świątek, Ł.; Ludwiczuk, A. Phytochemical Profile and Anticancer Potential of Endophytic Microorganisms from Liverwort Species, Marchantia polymorpha L. Molecules 2022, 27, 153. [Google Scholar] [CrossRef] [PubMed]
  16. Asakawa, Y.; Baser, K.H.C.; Erol, B.; Von Reuß, S.; Konig, W.A.; Ozenoglu, H.; Gokler, I. Volatile Components of Some Selected Turkish Liverworts. Nat. Prod. Commun. 2018, 13, 1934578X1801300729. [Google Scholar] [CrossRef]
  17. Ludwiczuk, A.; Biernasiuk, A.; Baj, T. Flowering or Spore-Forming Plants—the Case Studies on Antimicrobial Activity of Marchantia and Thymus Species. In Proceedings of the 68th Symposium on the Chemistry of Terpenes, Essential Oils and Aromatics (TEAC 2024), Minamiminowa, Japan, 26 October 2024; Volume 2AI-3, pp. 177–179. [Google Scholar]
  18. Matsuo, A.; Nakayama, N.; Nakayama, M. Enantiomeric Type Sesquiterpenoids of the Liverwort Marchantia polymorpha. Phytochemistry 1985, 24, 777–781. [Google Scholar] [CrossRef]
  19. Asakawa, Y.; Toyota, M.; Bischler, H.; Hattori, S. Comparative Study of Chemical Constituents of Marchantia Species. J. Hattori Bot. Lab. 1984, 57, 383. [Google Scholar]
  20. Ludwiczuk, A.; Nagashima, F.; Gradstein, S.; Asakawa, Y. Volatile Components from Selected Mexican, Ecuadorian, Greek, German and Japanese Liverworts. Nat. Prod. Commun. 2008, 3, 133–140. [Google Scholar] [CrossRef]
  21. Gleizes, M.; Pauly, G.; Suire, C. Les Essences Extraites Du Thalle Des Hepatiques II—La Fraction Sesquiterpenique de l’Essence de Marchantia polymorpha L. (Marchantiale). Le Bot. 1973, 56, 209–214. [Google Scholar]
  22. Asakawa, Y.; Tori, M.; Masuya, T.; Frahm, J.P. Ent-Sesquiterpenoids and Cyclic Bis(Bibenzyls) from the German Liverwort Marchantia polymorpha. Phytochemistry 1990, 29, 1577–1584. [Google Scholar] [CrossRef]
  23. Asakawa, Y.; Tori, M.; Takikawa, K.; Krishnamurty, H.G.; Kar, S.K. Cyclic Bis(Bibenzyls) and Related Compounds from the Liverworts Marchantia polymorpha and Marchantia palmata. Phytochemistry 1987, 26, 1811–1816. [Google Scholar] [CrossRef]
  24. Asakawa, Y.; Matsuda, R.; Takemoto, T.; Hattori, S.; Mizutani, M.; Inoue, H.; Suire, C.; Huneck, S. Chemosystematics of Bryophytes VII. The Distribution of Terpenoids and Aromatic Compounds in Some European and Japanese Hepaticae. J. Hattori Bot. Lab. 1981, 50, 107. [Google Scholar]
  25. Asakawa, Y.; Tokunaga, N.; Toyota, M.; Takemoto, T.; Suire, C. Chemosystematics of Bryophytes I. The Distribution of Terpenoids of Bryophytes. J. Hattori Bot. Lab. 1979, 45, 385. [Google Scholar]
  26. Hopkins, B.J.; Perold, G.W. (S)-2-Hydroxycuparene [p-(1,2,2-Trimethylcyclopentyl)-o-Cresol] and 3,4′-Ethylenebisphenol from a Liverwort, Marchantia polymorpha Linn. J. Chem. Soc. Perkin 1 1974, 32–36. [Google Scholar] [CrossRef]
  27. Rieck, A.; Bülow, N.; Fricke, C.; Saritas, Y.; König, W.A. (−)-1(10),11-eremophiladien-9β-ol from the liverwort Marchantia polymorpha ssp. aquatica. Phytochemistry 1997, 45, 195–197. [Google Scholar] [CrossRef]
  28. Kanasaki, T.; Ohta, K. Isolation and Identification of Costunolide as a Piscicidal Component of Marchantia polymorpha. Agric. Biol. Chem. 1976, 40, 1239. [Google Scholar] [CrossRef]
  29. Li, X.; Syrkin Wurtele, E.; Lamotte, C.E. Abscisic Acid Is Present in Liverworts. Int. J. Plant Biochem. 1994, 37, 625–627. [Google Scholar] [CrossRef]
  30. Toyota, M. Chemical Constituents of Marchantia Polymorpha, Riccardia Multifida and Plagiochila Genus (Hepaticae). Ph.D. Thesis, Tokushima Bunri University, Tokushima, Japan, 1987. [Google Scholar]
  31. Van Nguyen, N.K.; Tran, H.D.-T.; Duong, T.-H.; Tuyen Pham, N.K.; Trang Nguyen, T.Q.; Thao Nguyen, T.N.; Chavasiri, W.; Nguyen, N.-H.; Tri Nguyen, H. Bio-Guided Isolation of Alpha-Glucosidase Inhibitory Compounds from Vietnamese Liverwort Marchantia polymorpha: In Vitro and in Silico Studies. RSC Adv. 2023, 13, 35481–35492. [Google Scholar] [CrossRef] [PubMed]
  32. Asakawa, Y.; Toyota, M.; Takeda, R.; Matsuda, R.; Gradstein, S.R.; Takikawa, K.; Takemoto, T. New Diterpenoids from Lejeuneaceae, Porellaceae and Marchantiaceae. In Proceedings of the 27th Symposium on Chemistry of Terpenes, Essential Oils and Aromatics, Nagasaki, Japan, 13–15 October 1983; p. 58. [Google Scholar]
  33. Asakawa, Y.; Okada, K.; Perold, G.W. Distribution of Cyclic Bis(Bibenzyls) in the South African Liverwort Marchantia polymorpha. Phytochemistry 1988, 27, 161–163. [Google Scholar] [CrossRef]
  34. Patterson, G.W.; Wolfe, G.R.; Salt, T.A.; Chiu, P.L. Sterols of Bryophytes with Emphasis on the Configuration at C-24. In Bryophytes: Their Chemistry and Chemical Taxonomy; Oxford University Press: Oxford, UK, 1990; p. 103. [Google Scholar]
  35. Cai, Y.Y.; Chen, T.; Cao, J.F. Antimicrobial and Antioxidant Metabolites from the Cultured Suspension Cells of Marchantiapolymorpha L. Nat. Prod. Commun. 2022, 17, 1934578X221096172. [Google Scholar] [CrossRef]
  36. Abe, S.; Ohta, Y. Lunularic Acid in Cell Suspension Cultures of Marchantia polymorpha. Phytochemistry 1983, 22, 1917–1920. [Google Scholar] [CrossRef]
  37. Adam, K.P. Marchantia polymorpha (Liverwort): Culture and Production of Metabolites. In Medicinal and Aromatic Plants IX; Bajaj, Y.P.S., Ed.; Springer: Berlin/Heidelberg, Germany, 1996; pp. 186–201. ISBN 978-3-662-08618-6. [Google Scholar]
  38. Ohta, Y.; Abe, S.; Komura, H.; Kobayashi, M. Prelunularic Acid, a Probable Immediate Precursor of Lunularic Acid, in Suspension-Cultured Cells of Marchantia polymorpha. J. Hattori Bot. Lab. 1984, 56, 249. [Google Scholar]
  39. Ohta, Y.; Abe, S.; Komura, H.; Kobayashi, M. Prelunularic Acid, a Probable Immediate Precursor of Lunularic Acid. First Example of a “Prearomatic” Intermediate in the Phenylpropanoid-Polymalonate Pathway. J. Am. Chem. Soc. 1983, 105, 4480. [Google Scholar] [CrossRef]
  40. Qu, J.B.; Xie, C.F.; Ji, M.; Shi, Y.Q.; Lou, H.X. Water-Soluble Constituents from the Liverwort Marchantia polymorpha. Helv. Chim. Acta 2007, 90, 2109–2115. [Google Scholar] [CrossRef]
  41. Fang, L.; Guo, H.F.; Lou, H.X. Three New Bibenzyl Derivatives from the Chinese Liverwort Marchantia polymorpha L. Helv. Chim. Acta 2007, 90, 748–752. [Google Scholar] [CrossRef]
  42. Niu, C.; Qu, J.B.; Lou, H.X. Antifungal Bis[Bibenzyls] from the Chinese Liverwort Marchantia polymorpha L. Chem. Biodivers. 2006, 3, 34–40. [Google Scholar] [CrossRef] [PubMed]
  43. Sabovljević, M.S.; Vujičić, M.; Wang, X.; Garraffo, H.M.; Bewley, C.A.; Sabovljević, A. Production of the Macrocyclic Bis-Bibenzyls in Axenically Farmed and Wild Liverwort Marchantia polymorpha L. Subsp. ruderalis Bischl. et Boisselier. Plant Biosyst. 2017, 151, 414–418. [Google Scholar] [CrossRef]
  44. Asakawa, Y. Phytochemistry of Hepaticae: Isolation of Biologically Active Aromatic Compounds and Terpenoids. Rev. Latinoam. Quím. 1984, 14, 109. [Google Scholar]
  45. Asakawa, Y.; Toyota, M.; Matsuda, R.; Takikawa, K.; Takemoto, T. Distribution of Novel Cyclic Bisbibenzyls in Marchantia and Riccardia Species. Phytochemistry 1983, 22, 1413–1415. [Google Scholar] [CrossRef]
  46. Asakawa, Y.; Matsuda, R.; Toyota, M.; Suire, C.; Takemoto, T.; Hattori, S. Phylogenetic Evolution of the Hepaticae Using by Chemical Character. In Proceedings of the 25th Symposium on Chemistry of Terpenes, Essential Oils and Aromatics, Yamaguchi, Japan, 2 October 1981; p. 92. [Google Scholar]
  47. Konoshima, M. Phytochemical Studies on the Liverworts Marchantia, Reboulia and Wiesnerella. Master’s Thesis, Tokushima Bunri University, Tokushima, Japan, 1998. [Google Scholar]
  48. Oiso, Y.; Toyota, M.; Asakawa, Y. Occurrence of Digalactopyranosylmonoacylglycerol in the Liverwort Marchantia polymorpha. J. Hattori Bot. Lab. 1999, 86, 169. [Google Scholar]
  49. Campbell, E.O.; Markham, K.R.; Moore, N.A.; Porter, L.J.; Wallace, J.W. Taxonomic and Phylogenetic Implications of Comparative Flavonoid Chemistry of Species in the Family Marchantiaceae. J. Hattori Bot. Lab. 1979, 45, 185. [Google Scholar]
  50. Markham, K.R.; Porter, L.J. Flavonoids of the Liverwort Marchantia polymorpha. Phytochemistry 1974, 13, 1937–1942. [Google Scholar] [CrossRef]
  51. Markham, K.R.; Porter, L.J. Production of an Auron by Bryophytes in the Reproductive Phase. Phytochemistry 1978, 17, 159–160. [Google Scholar] [CrossRef]
  52. Kunz, S.; Burkhardt, G.; Becker, H. Riccionidins A and B, Anthocyanidins from the Cell Walls of the Liverwort Ricciocarpos natans. Phytochemistry 1993, 35, 233–235. [Google Scholar] [CrossRef]
  53. Saruwatari, M.; Takio, S.; Ono, K. Low Temperature-Induced Accumulation of Eicosapentaenoic Acids in Marchantia polymorpha Cells. Phytochemistry 1999, 52, 367–372. [Google Scholar] [CrossRef]
  54. Shinmen, Y.; Katoh, K.; Shimizu, S.; Jareonkitmongkol, S.; Yamada, H. Production of Arachidonic Acid and Eicosapentaenoic Acids by Marchantia polymorpha in Cell Culture. Phytochemistry 1991, 30, 3255–3260. [Google Scholar] [CrossRef]
  55. Boisselier-Dubayle, M.C.; Jubier, M.F.; Lejeune, B.; Bischler, H. Genetic Variability in the Three Subspecies of Marchantia polymorpha (Hepaticae): Isozymes, RFLP and RAPD Markers. Taxon 1995, 44, 363–376. [Google Scholar] [CrossRef]
  56. Shimamura, M. Marchantia polymorpha: Taxonomy, Phylogeny and Morphology of a Model System. Plant Cell Physiol. 2016, 57, 230–256. [Google Scholar] [CrossRef] [PubMed]
  57. Bischler-Causse, H.; Boisselier-Dubayle, M.C. Lectotypification of Marchantia polymorpha L. J. Bryol. 1991, 16, 361–365. [Google Scholar] [CrossRef]
  58. Linde, A.-M.; Sawangproh, W.; Cronberg, N.; Szövényi, P.; Lagercrantz, U. Evolutionary History of the Marchantia polymorpha Complex. Front. Plant Sci. 2020, 11, 829. [Google Scholar] [CrossRef]
  59. Asakawa, Y.; Toyota, M.; Nakaishi, E.; Tada, Y. Distribution of Terpenoids and Aromatic Compounds in New Zealand Liverworts. J. Hattori Bot. Lab. 1996, 80, 271–295. [Google Scholar] [CrossRef]
  60. Stelmasiewicz, M. The Search for Biologically Active Compounds in the Common Liverwort (Marchantia polymorpha L.) and Its Endophytes. Ph.D. Thesis, Medical University of Lublin, Lublin, Poland, 2023. [Google Scholar]
  61. Tanaka, M.; Esaki, T.; Kenmoku, H.; Koeduka, T.; Kiyoyama, Y.; Masujima, T.; Asakawa, Y.; Matsui, K. Direct Evidence of Specific Localization of Sesquiterpenes and Marchantin A in Oil Body Cells of Marchantia polymorpha L. Phytochemistry 2016, 130, 77–84. [Google Scholar] [CrossRef]
  62. Son, N.C.T.; Tan, T.Q.; Lien, D.T.M.; Huong, N.T.M.; Tuyen, P.N.K.; Phung, N.K.P.; Phuong, Q.N.D.; Thu, N.T.H. Five Phenolic Compounds from Marchantia polymorpha L. and Their in Vitro Antibacterial, Antioxidant and Cytotoxic Activities. Vietnam J. Chem. 2020, 58, 810–814. [Google Scholar] [CrossRef]
  63. Friederich, S.; Maier, U.H.; Deus-Neumann, B.; Asakawa, Y.; Zenk, M.H. Biosynthesis of Cyclic Bis(Bibenzyls) in Marchantia polymorpha. Phytochemistry 1999, 50, 589–598. [Google Scholar] [CrossRef]
  64. Asakawa, Y.; Toyota, M.; Nagashima, F.; Hashimoto, T. Chemical Constituents of Selected Japanese and New Zealand Liverworts. Nat Prod Communn 2008, 3, 289–300. [Google Scholar] [CrossRef]
  65. Ludwiczuk, A.; Raharivelomanana, P.; Pham, A.; Bianchini, J.P.; Asakawa, Y. Chemical Variability of the Tahitian Marchantia hexaptera Reich. Phytochem. Lett. 2014, 10, xcix–ciii. [Google Scholar] [CrossRef]
  66. Toyota, M.; Asakawa, Y. Sesquiterpenoids and Cyclic Bis(Bibenzyls) from the Pakistani Liverwort Plagiochasma appendiculatum. J. Hattori Bot. Lab. 1999, 86, 161–167. [Google Scholar] [CrossRef]
  67. Xiong, R.L.; Zhang, J.Z.; Liu, X.Y.; Deng, J.Q.; Zhu, T.T.; Ni, R.; Tan, H.; Sheng, J.Z.; Lou, H.X.; Cheng, A.X. Identification and Characterization of Two Bibenzyl Glycosyltransferases from the Liverwort Marchantia polymorpha. Antioxidants 2022, 11, 735. [Google Scholar] [CrossRef]
  68. Asakawa, Y.; Ludwiczuk, A.; Nagashima, F. Phytochemical and Biological Studies of Bryophytes. Phytochemistry 2013, 91, 52–80. [Google Scholar] [CrossRef]
  69. Chen, F.; Ludwiczuk, A.; Wei, G.; Chen, X.; Crandall-Stotler, B.; Bowman, J.L. Terpenoid Secondary Metabolites in Bryophytes: Chemical Diversity, Biosynthesis and Biological Functions. Crit. Rev. Plant Sci. 2018, 37, 210–231. [Google Scholar] [CrossRef]
  70. Das, K.; Kityania, S.; Nath, R.; Das, S.; Nath, D.; Talukdar, A.D. Bioactive Compounds from Bryophytes. In Bioactive Compounds in Bryophytes and Pteridophytes; Murthy, H.N., Ed.; Springer International Publishing: Cham, Switzerland, 2022; pp. 1–15. ISBN 978-3-030-97415-2. [Google Scholar]
  71. Gahtori, D.; Chaturvedi, P. Antifungal and Antibacterial Potential of Methanol and Chloroform Extracts of Marchantia polymorpha L. Arch. Phytopathol. Plant Prot. 2011, 44, 726–731. [Google Scholar] [CrossRef]
  72. Mewari, N.; Kumar, P. Evaluation of Antifungal Potential of Marchantia polymorpha L., Dryopteris filix-mas (L.) Schott and Ephedra foliata Boiss. Against Phyto Fungal Pathogens. Arch. Phytopathol. Plant Prot. 2011, 44, 804–812. [Google Scholar] [CrossRef]
  73. Bu, H.; Shi, F.; Li, M.W.; Chen, X.; Liao, L.; Li, J. Screening of the Antibacterial Activity of Accompanying Weed Extracts Against Fusarium solani. Chin. J. Appl. Environ. Biol. 2023, 29, 460–465. [Google Scholar] [CrossRef]
  74. Mewari, N.; Kumar, P. Antimicrobial Activity of Extracts of Marchantia polymorpha. Pharm. Biol. 2008, 46, 819–822. [Google Scholar] [CrossRef]
  75. Guo, X.L.; Leng, P.; Yang, Y.; Yu, L.G.; Lou, H.X. Plagiochin E, a Botanic-derived Phenolic Compound, Reverses Fungal Resistance to Fluconazole Relating to the Efflux Pump. J. Appl. Microbiol. 2008, 104, 831–838. [Google Scholar] [CrossRef] [PubMed]
  76. Wu, X.; Cheng, A.; Sun, L.; Lou, H. Effect of Plagiochin E, an Antifungal Macrocyclic Bis(Bibenzyl), on Cell Wall Chitin Synthesis in Candida albicans. Acta Pharmacol. Sin. 2008, 29, 1478–1485. [Google Scholar] [CrossRef]
  77. Wu, X.-Z.; Cheng, A.-X.; Sun, L.-M.; Sun, S.-J.; Lou, H.-X. Plagiochin E, an Antifungal Bis(Bibenzyl), Exerts Its Antifungal Activity through Mitochondrial Dysfunction-Induced Reactive Oxygen Species Accumulation in Candida albicans. Biochim. Biophys. Acta 2009, 1790, 770–777. [Google Scholar] [CrossRef] [PubMed]
  78. Wu, X.-Z.; Chang, W.-Q.; Cheng, A.-X.; Sun, L.-M.; Lou, H.-X. Plagiochin E, an Antifungal Active Macrocyclic Bis(Bibenzyl), Induced Apoptosis in Candida albicans through a Metacaspase-Dependent Apoptotic Pathway. Biochim. Biophys. Acta 2010, 1800, 439–447. [Google Scholar] [CrossRef] [PubMed]
  79. Kamory, E.; Keseru, G.M.; Papp, B. Isolation and Antibacterial Activity of Marchantin A, a Cyclic Bis(Bibenzyl) Constituent of Hungarian Marchantia polymorpha. Planta Med. 1995, 61, 387–388. [Google Scholar] [CrossRef] [PubMed]
  80. Ivković, I.M.; Bukvički, D.R.; Novaković, M.M.; Ivanović, S.G.; Stanojević, O.J.; Nikolić, I.C.; Veljić, M.M. Antibacterial Properties of Thalloid Liverworts Marchantia polymorpha L., Conocephalum Conicum (L.) Dum. and Pellia Endiviifolia (Dicks.) Dumort. J. Serb. Chem. Soc. 2021, 86, 1249–1258. [Google Scholar] [CrossRef]
  81. Zhou, F.; Aipire, A.; Xia, L.; Halike, X.; Yuan, P.; Sulayman, M.; Wang, W.; Li, J. Marchantia polymorpha L. Ethanol Extract Induces Apoptosis in Hepatocellular Carcinoma Cells via Intrinsic- and Endoplasmic Reticulum Stress-Associated Pathways. Chin. Med. 2021, 16, 94. [Google Scholar] [CrossRef]
  82. Mishra, T.; Sahu, V.; Meena, S.; Pal, M.; Asthana, A.K.; Datta, D.; Upreti, D.K. A Comparative Study of in Vitro Cytotoxicity and Chemical Constituents of Wild and Cultured Plants of Marchantia polymorpha L. S. Afr. J. Bot. 2023, 157, 274–278. [Google Scholar] [CrossRef]
  83. Jensen, J.S.R.E.; Omarsdottir, S.; Thorsteinsdottir, J.B.; Ogmundsdottir, H.M.; Olafsdottir, E.S. Synergistic Cytotoxic Effect of the Microtubule Inhibitor Marchantin A from Marchantia polymorpha and the Aurora Kinase Inhibitor MLN8237 on Breast Cancer Cells In Vitro. Planta Med. 2012, 78, 448–454. [Google Scholar] [CrossRef] [PubMed]
  84. Gaweł-Bęben, K.; Osika, P.; Asakawa, Y.; Antosiewicz, B.; Głowniak, K.; Ludwiczuk, A. Evaluation of Anti-Melanoma and Tyrosinase Inhibitory Properties of Marchantin A, a Natural Macrocyclic Bisbibenzyl Isolated from Marchantia Species. Phytochem. Lett. 2019, 31, 192–195. [Google Scholar] [CrossRef]
  85. Stelmasiewicz, M.; Świątek, Ł.; Ludwiczuk, A. Chemical and Biological Studies of Endophytes Isolated from Marchantia polymorpha. Molecules 2023, 28, 2202. [Google Scholar] [CrossRef] [PubMed]
  86. Iwai, Y.; Murakami, K.; Gomi, Y.; Hashimoto, T.; Asakawa, Y.; Okuno, Y.; Ishikawa, T.; Hatakeyama, D.; Echigo, N.; Kuzuhara, T. Anti-Influenza Activity of Marchantins, Macrocyclic Bisbibenzyls Contained in Liverworts. PLoS ONE 2011, 6, e19825. [Google Scholar] [CrossRef]
  87. Jensen, S.; Omarsdottir, S.; Bwalya, A.G.; Nielsen, M.A.; Tasdemir, D.; Olafsdottir, E.S. Marchantin A, a Macrocyclic Bisbibenzyl Ether, Isolated from the Liverwort Marchantia polymorpha, Inhibits Protozoal Growth In Vitro. Phytomedicine 2012, 19, 1191–1195. [Google Scholar] [CrossRef] [PubMed]
  88. Otoguro, K.; Ishiyama, A.; Iwatsuki, M.; Namatame, M.; Nishihara-Tukashima, A.; Kiyohara, H.; Hashimoto, T.; Asakawa, Y.; Ōmura, S.; Yamada, H. In Vitro Antitrypanosomal Activity of Bis(Bibenzyls)s and Bibenzyls from Liverworts against Trypanosoma brucei. J. Nat. Med. 2012, 66, 377–382. [Google Scholar] [CrossRef] [PubMed]
  89. Schwartner, C.; Bors, W.; Michel, C.; Franck, U.; Müller-Jakic, B.; Nenninger, A.; Asakawa, Y.; Wagner, H. Effect of Marchantins and Related Compounds on 5-Lipoxygenase and Cyclooxygenase and Their Antioxidant Properties: A Structure Activity Relationship Study. Phytomedicine 1995, 2, 113–117. [Google Scholar] [CrossRef]
  90. Asif, A.; Ishtiaq, S.; Kamran, S.H.; Youssef, F.S.; Lashkar, M.O.; Ahmed, S.A.; Ashour, M.L. UHPLC−QTOF−MS Metabolic Profiling of Marchantia polymorpha and Evaluation of Its Hepatoprotective Activity Using Paracetamol-Induced Liver Injury in Mice. ACS Omega 2023, 8, 19037–19046. [Google Scholar] [CrossRef]
  91. Zhang, K.; Cao, H.; Gao, Y.; Zhong, M.; Wang, Y.; Guan, Y.; Wei, R.; Jin, L. Marchantia polymorpha L. Flavonoids Protect Liver From CCl4-Induced Injury by Antioxidant and Gene-Regulatory Effects. Altern. Ther. Health Med. 2022, 28, 34–41. [Google Scholar]
  92. Harinantenaina, L.; Quang, D.N.; Takeshi, N.; Hashimoto, T.; Kohchi, C.; Soma, G.I.; Asakawa, Y. Bis(Bibenzyls) from Liverworts Inhibit Lipopolysaccharide-Induced Inducible NOS in RAW 264.7 Cells: A Study of Structure-Activity Relationships and Molecular Mechanism. J. Nat. Prod. 2005, 68, 1779–1781. [Google Scholar] [CrossRef] [PubMed]
  93. Esplugues, J.V. NO as a Signalling Molecule in the Nervous System. Br. J. Pharmacol. 2002, 135, 1079. [Google Scholar] [CrossRef]
  94. Ludwiczuk, A.; Asakawa, Y. Terpenoids and Aromatic Compounds from Bryophytes and Their Central NervousSystem Activity. Curr. Org. Chem. 2020, 24, 113–128. [Google Scholar] [CrossRef]
  95. Keseru, G.M.; Nógrádi, M. The Biological Activity of Cyclic Bis(Bibenzyls): A Rational Approach. Bioorg. Med. Chem. 1995, 3, 1511–1517. [Google Scholar] [CrossRef]
  96. Bowman, J.L. A Brief History of Marchantia from Greece to Genomics. Plant Cell Physiol. 2016, 57, 210–229. [Google Scholar] [CrossRef] [PubMed]
  97. Saxena, D.K. Harinder Uses of Bryophytes. Resonance 2004, 9, 56–65. [Google Scholar] [CrossRef]
  98. Stelmasiewicz, M.; Świątek, Ł.; Gibbons, S.; Ludwiczuk, A. Bioactive Compounds Produced by Endophytic Microorganisms Associated with Bryophytes—The “Bryendophytes”. Molecules 2023, 28, 3246. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Marchantia polymorpha—umbrella liverwort: (a) female and (b) male plant. (Photos by Prof. Yoshinori Asakawa, Tokushima Bunri University, Japan).
Figure 1. Marchantia polymorpha—umbrella liverwort: (a) female and (b) male plant. (Photos by Prof. Yoshinori Asakawa, Tokushima Bunri University, Japan).
Molecules 30 00558 g001
Figure 2. Selected sesquiterpenoids characteristic of M. polymorpha.
Figure 2. Selected sesquiterpenoids characteristic of M. polymorpha.
Molecules 30 00558 g002
Figure 3. Chemical structures of marchantin-type bisbibenzyls.
Figure 3. Chemical structures of marchantin-type bisbibenzyls.
Molecules 30 00558 g003
Figure 4. Chemical structures of some riccardins and perrottetin E.
Figure 4. Chemical structures of some riccardins and perrottetin E.
Molecules 30 00558 g004
Figure 5. Chemical structures of some diterpenoids and triterpenoids, flavonoids, phenanthrenes, and phthalides.
Figure 5. Chemical structures of some diterpenoids and triterpenoids, flavonoids, phenanthrenes, and phthalides.
Molecules 30 00558 g005
Table 1. Secondary metabolites found in Marchantia polymorpha.
Table 1. Secondary metabolites found in Marchantia polymorpha.
No.CompoundsFormulaGeographic OriginReferences
MONOTERPENOIDS
1LimoneneC10H16USA *[14]
SESQUITERPENOIDS
acoranes
2β-AcoradieneC15H24Poland[15]
3α-NeocallitropseneC15H26Poland[15]
4β-AlaskeneC15H24Poland[15]
5Acorenone BC15H24OPoland[15]
aromadendranes
6α-GurjuneneC15H24Serbia, Turkey, USA *[14,16,17]
7AromadendreneC15H24Turkey[16]
8ViridiflorolC15H26OSerbia[17]
barbatenes
9α-BarbateneC15H24Japan[18]
10β-BarbateneC15H24Japan, Turkey[16,18,19,20]
bisabolanes
11β-BisaboleneC15H24Japan[19]
caryophyllanes
12β-CaryophylleneC15H24Japan[19]
cedranes
13α-CedreneC15H24Japan[19]
147-epi-α-CedreneC15H24Poland[15]
15β-CedreneC15H24France[21]
chamigranes
16α-ChamigreneC15H24Japan, Germany, India[20,22,23]
17β-ChamigreneC15H24Germany, India, Poland, Japan, France, Serbia, USA *[14,15,17,19,22,23,24,25]
18ent-9-oxo-α-Chamigrene
(Laurencenone C)
C15H22OJapan, Germany, Poland[20,22,24]
cuparanes
19CupareneC15H24Japan, Poland, France, Serbia, USA *[14,15,17,18,19,25]
20α-CupreneneC15H24Japan, France, Poland[15,19,20]
21β-CupreneneC15H24Japan, France[19]
22γ-CupreneneC15H24Japan[20]
23δ-CupreneneC15H24Japan, France, Poland[15,19,20]
24β-MicrobioteneC15H24Poland[15]
252-Cuparenol (=Cuparophenol,
δ-Cuparenol, 2-Hydroxycuparene)
C15H22OSouth Africa, Japan, France[18,19,24,26]
26ent-CuprenenolC15H26OJapan, France[19]
27Cyclopropanecuparenol C15H26OJapan, France, Poland, Serbia[15,17,19,20]
28epi-Cyclopropanecuparenol C15H26OJapan, France, Poland[15,19]
cyclomyltaylanes
29Cyclomyltaylenol C15H26OSerbia[17]
elemanes and bicycloelemanes
30β-ElemeneC15H24Japan[19,21]
31δ-ElemeneC15H24Japan[19,24,25]
32BicycloelemeneC15H24Japan, France[19]
eudesmanes
33α-SelineneC15H24Turkey, Poland, Serbia[15,17,19]
34ent-β-SelineneC15H24India, Japan[19,23]
35α-EudesmolC15H26OTurkey[16]
36β-EudesmolC15H26OTurkey[16]
eremophilanes
37EremophileneC15H24France[21]
381(10),11-Eremophiladien-9β-olC15H24OGermany[27]
germacranes
39CostunolideC15H20O2Japan[28]
guaianes
405-Guaia-11-olC15H26OSerbia[17]
herbertanes
41β-HerbertenolC15H22OJapan, Poland[15,18,19]
42ent-α-HerbertenolC15H22OGermany [22]
himachalanes
43α-HimachaleneC15H24USA *[14,25]
monocyclofarnesanes
44(2Z,4E)-Abscisic acidC15H20O3USA[29]
45(2E,4E)-Abscisic acidC15H20O3USA[29]
thujopsanes
46ent-ThujopseneC15H24Japan, Poland, France, Serbia, USA *[14,15,17,18,19,20,30]
47ent-Thujopsan-7β-olC15H26OJapan, Germany[20,22]
48ent-Thujopsenone
(=Thujops-3-en-5-one)
C15H22OJapan, France, Serbia[17,18,19,20]
widdranes
49WiddrolC15H26OJapan[18,19]
DITERPENOIDS
50MarchanolC20H32O2Vietnam[31]
51Labda-7,13E-dien-15-olC20H34OJapan[19,30,32]
52Vitexilactone C22H34O4Vietnam[31]
53PhytolC20H40OSouth Africa, Poland[15,19,33]
STEROLS and TRITERPENOIDS
54Campesterol C28H48OSouth Africa, Germany, Japan, India, Taiwan[22,23,24,33,34]
55BrassicasterolC28H46OJapan[24]
56DihydrobrassicasterolC28H48OTaiwan[34]
57StigmasterolC29H48OSouth Africa, Japan, Germany[22,24,33]
58SitosterolC29H50OSouth Africa, Germany, Taiwan[22,33,34]
59Clionasterol (24β-ethyl)C29H50OTaiwan[34]
6012-Oleanene-3-oneC30H48OVietnam[31]
61Ursolic acidC30H48O3Vietnam[31]
623,11-Dioxoursolic acidC30H44O4Vietnam[31]
BIBENZYLS
63LunularinC14H14O2Germany, Vietnam, China)[19,22,31,35]
64Lunularic acidC15H14O4Japan *, Germany[36,37,38]
65Prelunularic acidC15H16O5Japan[38,39]
662,5-Di-O-β-d-glucopyranosyl- 4′-hydroxybibenzylC26H34O13China[40]
672-[3-(Hydroxymethyl) phenoxy]-3-[2-(4-hydroxyphenyl) ethyl]phenolC21H20O4China[41]
BISBIBENZYLS
68Riccardin C (=plagiochin G)C28H24O4South Africa, India, Vietnam, China[23,31,33,35]
69Riccardin D (=plagiochin E)C28H24O4China[42]
70Riccardin G (=plagiochin E methyl ether)C29H26O4China *[35]
71Riccardin HC31H28O4China[42]
72Isoriccardin CC28H24O4India, Vietnam[23,31]
73Isoriccardin DC28H24O4China[41]
7413,13′-O-Isopropylidenericcardin DC31H28O4China[42]
75Polymorphatin AC28H24O4China[41]
76Marchantin AC28H24O5China, Germany, India, Japan, Serbia, Vietnam[19,22,23,25,30,31,35,42,43,44,45,46]
777′,8′-Dehydromarchantin AC28H24O4Serbia *[43]
78Marchantin BC28H24O6China, Germany Japan[19,22,30,35,42,43,45]
79Marchantin CC28H24O4South Africa, Germany, India, Japan, Serbia *[19,22,23,30,33,43,45]
80Marchantin DC28H24O6Germany, India, China [22,23,30,35,45,47]
81Marchantin EC29H26O6China, Germany, India, France, Serbia *[19,22,23,30,35,42,43,45]
82Marchantin FC28H24O7South Africa, China[35]
83Marchantin GC28H22O6Japan[47]
84Marchantin HC28H24O5South Africa,[33]
85Marchantin JC30H28O6China, Germany[22,41]
86Marchantin KC29H26O7Germany, Vietnam, China[22,31,35]
87Marchantin LC28H24O6Germany[22]
88Isomarchantin CC28H24O4India[23]
89Neomarchantin AC28H24O4China[42]
90Perrottetin EC28H26O4China, India[23,35,41]
OTHER AROMATICS
913R-(3,4-Dimethoxybenzyl)-
5,7-dimethoxyphthalide
C19H20O6Vietnam[31]
92MarchatosideC20H22O7Vietnam[31]
933-(3,4-Dihydroxyphenyl)-
8-hydroxyisocoumarin
C15H10O5Germany * [37]
942,3-Dimethoxy-7-hydroxy-
phenanthrene
C16H14O3Germany *[37]
952,7-Dihydroxy-3-methoxy-
phenanthrene
C15H12O3Germany *[37]
963,3′-Dimethoxy-2,2′,7,7′-tetra-
hydroxy-1,1′-biphenanthrene
C30H22O6Germany *[37]
972-Hydroxy-3,7-dimethoxy phenanthreneC16H14O3India[23]
98m-HydroxybenzaldehydeC7H6O2Germany[22]
99p-HydroxybenzaldehydeC7H6O2South Africa, Germany[22,33]
1003-Methoxy-2,2′,3′,7,7′-pentahydroxy- 1,1′-biphenanthreneC29H20O6Germany *[37]
1012,2′,3,3′,7,7′-Hexahydroxy-
1,1′-biphenanthrene
C28H18O6Germany *[37]
1022-(3,4-Dihydroxyphenyl)-ethyl-
β-d-allopyranoside
C14H20O8China[40]
1032-(3,4-Dihydroxyphenyl)-ethyl-
β-d-glucopyranoside
C14H20O8China, Germany *, Japan[37,40,48]
1042-(3,4-Dihydroxyphenyl)-ethyl-
O-α-l-rhamnopyranosyl-(1→2)-
β-d- allopyranoside
C20H30O12China[40]
1052-(3,4-Dihydroxyphenyl)-ethyl-
O-β-d-xylopyranosyl-(1→6)-
O-β-d-allopyranoside
C19H28O12China[40]
106SalidrosideC14H20O7Japan[48]
107Indole acetic acid C9H7O2NUSA[29]
FLAVONOIDS
108ApigeninC15H10O5Germany *,
New Zealand
[37,49,50]
109Apigenin-7-O-β-D-glucuronideC21H18O11New Zealand[49,50]
110Apigenin-7,4′-di-O-glucuronideC27H26O17New Zealand[49,50]
111LuteolinC15H10O6Germany[22,49,50]
112Luteolin-7-O-β-D-glucuronideC21H18O12New Zealand[49,50]
113Luteolin-7,3′-di-O-β-glucuronideC27H26O18New Zealand[49,50]
114Luteolin-7,4′-di-O-β-glucuronideC27H26O18New Zealand[49,50]
115Luteolin-3′4′-di-O-β-glucuronideC27H26O18New Zealand[49,50]
116Luteolin-3′-O-β-glucuronideC21H18O12New Zealand[49,50]
117Luteolin-7,3′4′-tri-O-β-glucuronide New Zealand[49,50]
118ArtemetinC20H20O8Vietnam[31]
119KaempferolC15H10O6Vietnam[31]
120QuercetinC15H10O7Vietnam[31]
121Aureusidin-6-O-g1ucuronideC21H18O12New Zealand[51]
1225,3′,4′-Trihydroxyisoflavone-
7-O-β-d-glucopyranoside
(=Orobol-7-O-glucoside)
C21H20O11China[40]
123Riccionidin AC15H9O6Germany *[52]
124Riccionidin BC30H17O12Germany *[52]
LIPIDS
125Palmitic acid (16:0)
(=Hexadecanoic acid)
C16H32O2Japan *[20,53]
126Ethyl palmitate (=Hexadecanoic acid ethyl ester)C18H36O2Japan[20]
127Stearic acid (18:0)
(=Octadecanoic acid)
C18H36O2Japan *[53]
128Palmitoleic acid (16:1n-7)
(=9-Hexadecenoic acid)
C16H30O2Japan *[53]
129Oleic acid (18:1n-9)
(=9-Octadecenoic acid)
C18H34O2Japan *[53]
130Linoleic acid (18:2n-6)
(=9,12-Octadecadienoic acid)
C18H32O2Japan *[20,53]
131α-Linolenic acid (18:3n-3)
(=9,12,15-Octadecatrienoic acid)
C18H30O2Japan *[53]
132Arachidonic acid (20:4n-6)
(=5,8,11,14-Eicosatetraenoic acid)
C20H32O2Japan *[53,54]
133EPA (20:5n-3)
(=5,8,11,14,17-Eicosapentaenoic acid)
C20H30O2Japan *[53,54]
134Oxacycloheptadecan-2-oneC16H30O2Japan[20]
OTHER COMPOUNDS
135Shikimic acid 4-(β-d-xylopyranoside)C12H18O9China[40]
* axenic or cell culture.
Table 2. Distribution of sesquiterpenoids and bisbibenzyls in relation to M. polymorpha subspecies and geographical origin.
Table 2. Distribution of sesquiterpenoids and bisbibenzyls in relation to M. polymorpha subspecies and geographical origin.
Characteristic CompoundsSubspeciesGeographical Origin
MprMppMpmJapanPolandGermanyFranceSerbiaTurkeyIndiaChinaVietnamSouth AfricaUSA
SESQUITERPENOIDS
Acoranes
Aromadendranes ✓ *
Barbatanes
Bisabolanes
Caryophyllanes
Cedranes
Chamigranes ✓ *
Cuparanes ✓ *
Cyclomyltaylanes
Elemanes
Eudesmanes
Eremophillanes
Germacranes
Guaianes
Herbertanes
Himachalanes ✓ *
Monocyclofarnesanes
Thujopsanes ✓ *
Widdranes
BISBIBENZYLS
Marchantin A
Marchantin B
Marchantin C ✓ *
Marchantin D
Marchantin E ✓ *
Marchantin F
Marchantin G
Marchantin H
Marchantin J
Marchantin K
Marchantin L
Isomarchantin C
Neomarchantin A
Riccardin C
Riccardin D
Riccardin G ✓ *
Riccardin H
Isoriccardin C
Isoriccardin D
Perrottetin E
* cell culture; Mpr—M. polymorpha subsp. ruderalis; Mpp—M. polymorpha subsp. polymorpha; Mpm—M. polymorpha subsp. montivagans.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Nowaczyński, F.; Nicoletti, R.; Zimowska, B.; Ludwiczuk, A. Marchantia polymorpha as a Source of Biologically Active Compounds. Molecules 2025, 30, 558. https://doi.org/10.3390/molecules30030558

AMA Style

Nowaczyński F, Nicoletti R, Zimowska B, Ludwiczuk A. Marchantia polymorpha as a Source of Biologically Active Compounds. Molecules. 2025; 30(3):558. https://doi.org/10.3390/molecules30030558

Chicago/Turabian Style

Nowaczyński, Filip, Rosario Nicoletti, Beata Zimowska, and Agnieszka Ludwiczuk. 2025. "Marchantia polymorpha as a Source of Biologically Active Compounds" Molecules 30, no. 3: 558. https://doi.org/10.3390/molecules30030558

APA Style

Nowaczyński, F., Nicoletti, R., Zimowska, B., & Ludwiczuk, A. (2025). Marchantia polymorpha as a Source of Biologically Active Compounds. Molecules, 30(3), 558. https://doi.org/10.3390/molecules30030558

Article Metrics

Back to TopTop